Aerovate Cash vs Net Debt Analysis

AVTE Stock  USD 2.32  0.04  1.69%   
Aerovate Therapeutics financial indicator trend analysis is way more than just evaluating Aerovate Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aerovate Therapeutics is a good investment. Please check the relationship between Aerovate Therapeutics Cash and its Net Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aerovate Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Aerovate Stock refer to our How to Trade Aerovate Stock guide.

Cash vs Net Debt

Cash vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aerovate Therapeutics Cash account and Net Debt. At this time, the significance of the direction appears to have pay attention.
The correlation between Aerovate Therapeutics' Cash and Net Debt is -1.0. Overlapping area represents the amount of variation of Cash that can explain the historical movement of Net Debt in the same time period over historical financial statements of Aerovate Therapeutics, assuming nothing else is changed. The correlation between historical values of Aerovate Therapeutics' Cash and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash of Aerovate Therapeutics are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Cash i.e., Aerovate Therapeutics' Cash and Net Debt go up and down completely randomly.

Correlation Coefficient

-1.0
Relationship DirectionNegative 
Relationship StrengthStrong

Cash

Cash refers to the most liquid asset of Aerovate Therapeutics, which is listed under current asset account on Aerovate Therapeutics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Aerovate Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Aerovate Therapeutics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.
Most indicators from Aerovate Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aerovate Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aerovate Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Aerovate Stock refer to our How to Trade Aerovate Stock guide.At present, Aerovate Therapeutics' Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting.
 2022 2023 2024 (projected)
Interest Income1.8M5.2M2.6M
Cost Of Revenue68K96K49.5K

Aerovate Therapeutics fundamental ratios Correlations

-0.80.580.661.00.95-0.95-0.740.850.94-0.431.00.47-0.760.730.121.01.01.00.570.970.69-0.430.7-0.690.7
-0.8-0.61-0.66-0.77-0.780.790.71-0.72-0.760.47-0.8-0.510.28-0.65-0.57-0.76-0.8-0.79-0.58-0.79-0.60.47-0.610.62-0.61
0.58-0.610.990.540.8-0.43-0.980.760.4-0.920.580.96-0.560.940.630.540.580.540.990.660.83-0.920.83-0.90.86
0.66-0.660.990.620.86-0.51-0.990.810.48-0.910.660.94-0.620.970.60.620.660.620.980.720.85-0.910.87-0.930.89
1.0-0.770.540.620.93-0.95-0.70.820.95-0.41.00.44-0.780.70.061.01.01.00.530.960.66-0.40.67-0.660.67
0.95-0.780.80.860.93-0.85-0.90.90.84-0.680.950.71-0.80.90.280.930.940.930.780.940.81-0.680.83-0.860.84
-0.950.79-0.43-0.51-0.95-0.850.58-0.64-1.00.37-0.95-0.380.66-0.540.0-0.95-0.95-0.96-0.45-0.86-0.440.37-0.450.46-0.46
-0.740.71-0.98-0.99-0.7-0.90.58-0.88-0.560.85-0.74-0.90.66-0.98-0.57-0.7-0.73-0.7-0.95-0.8-0.890.85-0.90.95-0.92
0.85-0.720.760.810.820.9-0.64-0.880.62-0.520.850.58-0.690.910.420.820.840.810.680.920.96-0.520.96-0.930.96
0.94-0.760.40.480.950.84-1.0-0.560.62-0.340.940.36-0.670.52-0.040.950.950.960.430.860.42-0.340.43-0.440.44
-0.430.47-0.92-0.91-0.4-0.680.370.85-0.52-0.34-0.43-0.990.49-0.81-0.48-0.4-0.43-0.4-0.95-0.44-0.571.0-0.620.74-0.65
1.0-0.80.580.661.00.95-0.95-0.740.850.94-0.430.47-0.760.730.131.01.01.00.570.970.69-0.430.7-0.690.7
0.47-0.510.960.940.440.71-0.38-0.90.580.36-0.990.47-0.520.850.540.430.470.430.980.50.64-0.990.67-0.780.7
-0.760.28-0.56-0.62-0.78-0.80.660.66-0.69-0.670.49-0.76-0.52-0.70.21-0.78-0.76-0.75-0.58-0.75-0.620.49-0.640.65-0.64
0.73-0.650.940.970.70.9-0.54-0.980.910.52-0.810.730.85-0.70.490.70.730.690.890.80.93-0.810.96-0.990.96
0.12-0.570.630.60.060.280.0-0.570.42-0.04-0.480.130.540.210.490.050.120.070.590.250.54-0.480.49-0.510.51
1.0-0.760.540.621.00.93-0.95-0.70.820.95-0.41.00.43-0.780.70.051.01.00.530.960.65-0.40.67-0.660.67
1.0-0.80.580.661.00.94-0.95-0.730.840.95-0.431.00.47-0.760.730.121.01.00.560.970.68-0.430.69-0.680.69
1.0-0.790.540.621.00.93-0.96-0.70.810.96-0.41.00.43-0.750.690.071.01.00.520.960.64-0.40.66-0.650.66
0.57-0.580.990.980.530.78-0.45-0.950.680.43-0.950.570.98-0.580.890.590.530.560.520.620.75-0.950.74-0.830.77
0.97-0.790.660.720.960.94-0.86-0.80.920.86-0.440.970.5-0.750.80.250.960.970.960.620.81-0.440.79-0.770.8
0.69-0.60.830.850.660.81-0.44-0.890.960.42-0.570.690.64-0.620.930.540.650.680.640.750.81-0.570.98-0.950.98
-0.430.47-0.92-0.91-0.4-0.680.370.85-0.52-0.341.0-0.43-0.990.49-0.81-0.48-0.4-0.43-0.4-0.95-0.44-0.57-0.620.74-0.65
0.7-0.610.830.870.670.83-0.45-0.90.960.43-0.620.70.67-0.640.960.490.670.690.660.740.790.98-0.62-0.991.0
-0.690.62-0.9-0.93-0.66-0.860.460.95-0.93-0.440.74-0.69-0.780.65-0.99-0.51-0.66-0.68-0.65-0.83-0.77-0.950.74-0.99-0.99
0.7-0.610.860.890.670.84-0.46-0.920.960.44-0.650.70.7-0.640.960.510.670.690.660.770.80.98-0.651.0-0.99
Click cells to compare fundamentals

Aerovate Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Aerovate Therapeutics is a strong investment it is important to analyze Aerovate Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aerovate Therapeutics' future performance. For an informed investment choice regarding Aerovate Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aerovate Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Aerovate Stock refer to our How to Trade Aerovate Stock guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aerovate Therapeutics. If investors know Aerovate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aerovate Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.13)
Return On Assets
(0.44)
Return On Equity
(0.74)
The market value of Aerovate Therapeutics is measured differently than its book value, which is the value of Aerovate that is recorded on the company's balance sheet. Investors also form their own opinion of Aerovate Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aerovate Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aerovate Therapeutics' market value can be influenced by many factors that don't directly affect Aerovate Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aerovate Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aerovate Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aerovate Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.